MycoMed Technologies I Products to Prevent Infection

MII Award Phase 1

//MII Award Phase 1

MII Award Phase 1

July 2015

Information sourced from TEDCO

MII Award

Maryland Innovation Initiative (MII) awards by TEDCO are given through the Innovation Commercialization Program, which provides funding to support the commercialization of qualified university technologies at two distinct stages: pre-commercial technology validation and commercialization planning (Phase I & 2 combined), and early-stage product development (company formation) (Phase III).

MycoMed Technologies LLC was one of the companies funded by the MII awards in 2015 for developing a test to be used as an aid to diagnose invasive aspergillosis, using technology licensed from the Johns Hopkins University, Baltimore, MD.

By | 2017-10-04T14:12:31+00:00 July 1st, 2015|